Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies
CD22 CAR T 细胞治疗 B 细胞急性淋巴细胞白血病 (B-ALL) 的疗效：两种生产策略的比较
期刊:Cytotherapy
影响因子:3.2
doi:10.1016/j.jcyt.2025.09.013
Dreyzin, Alexandra; Kramer, Anne Marijn; Yates, Bonnie; Wang, Hao-Wei; Sahaf, Bita; Yuan, Constance; Klysz, Dorota; Tunuguntla, Ramya; Ehlinger, Zachary; Reitberg, Skyler; Adebola, Serifat; Su, Angela; Ebina-Shibuya, Risa; Jia, Dongya; Achar, Sooraj; Patil, Sunita; Martin, Kathryn; Jeyakumar, Nikeshan; Davis, Kara L; Fry, Terry; Mackall, Crystal L; Taylor, Naomi; Altan-Bonnet, Gregoire; Highfill, Steven; Feldman, Steven; Stroncek, David F; Chien, Christopher; Schultz, Liora Michal; Frank, Matthew J; Muffly, Lori S; Shalabi, Haneen; Ramakrishna, Sneha; Shah, Nirali N
